News | ACC
March 20, 2018 — When patients who had a heart attack were given vouchers to cover their co-payments for medication to ...
March 20, 2018
Feature | Dave Fornell
Here is the list of the most popular articles and videos on the Diagnostic and Interventional Cardiology (DAIC) magazine ...
March 20, 2018
News | ACC
March 20, 2018 — Patients with acute coronary syndrome experienced a substantially lower rate of heart attack, stroke ...
March 20, 2018Sponsored Content
Feature | Information Technology
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
March 21, 2024
News | ACC
March 20, 2018 — A pill combining low doses of three blood pressure-lowering medications significantly increased the ...
March 20, 2018
News | ACC
March 20, 2018 — African-American men who received medical intervention aimed at controlling their high blood pressure ...
March 20, 2018
News | ACC
March 20, 2018 — Among people with a type of hole in the heart, known as patent foramen ovale (PFO), those who received ...
March 20, 2018Sponsored Content
Feature | Cardiac Imaging
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
March 05, 2024
Videos | Congenital Heart
A discussion with Ami Bhatt, M.D., director of the adult congenital heart program and outpatient cardiology ...
March 20, 2018
The combined rate of death from any cause, heart attack or stroke within 18 months was not significantly different in patients with acute coronary syndrome (ACS) who were randomly assigned to receive dual antiplatelet therapy (DAPT) for either six months or at least 12 months after receiving a drug-eluting stent. Patients who were given DAPT for only six months, however, had more than double the risk of a heart attack compared with those treated for at least 12 months, according to research presented at the American College of Cardiology’s (ACC) 67th Annual Scientific Session, March 10-12 in Orlando, Fla.
March 19, 2018
News | Wearables
For people at heightened risk for atrial fibrillation (AFib), a common heart rhythm disorder that also carries a high risk of stroke, wearing a self-adhering chest patch that records heart patterns may better detect the condition and facilitate more timely treatment than relying on usual care, according to one-year data presented at the American College of Cardiology’s 67th Annual Scientific Session, March 10-12 in Orlando, Fla.
March 19, 2018Sponsored Content
Blog
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...
December 11, 2023
Technology | Artificial Intelligence
March 19, 2018 — Philips recently announced the launch of HealthSuite Insights, including the Insights Marketplace, to ...
March 19, 2018
Videos | Cath Lab
A discussion with Hitinder Gurm, M.D., MBBS, FACC, professor, internal medicine, and associate chief clinical officer ...
March 15, 2018
Videos | Heart Valve Technology
Insights from the STS/ACC TVT Transcatheter Valve Registry, presented at the American College of Cardiology (ACC) 2018 ...
March 15, 2018Sponsored Content
Case Study | Hemodynamic Monitoring Systems
Change Healthcare Cardiology Hemodynamics is an integrated hemodynamic monitoring system for monitoring vital signs and ...
November 14, 2023
March 15, 2018 – Johnson & Johnson Medical Devices Companies announced today that Biosense Webster, Inc., who works in ...
March 15, 2018
Videos | FFR Technologies
An economic analysis of the DEFINE-FLAIR study comparing FFR vs. iFR, found a cost savings of nearly $900. The late ...
March 15, 2018
News | ACC
March 15, 2018 — For people living with both Type 2 diabetes and heart failure, taking an aspirin each day appears to ...
March 15, 2018© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now